Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Sling gets $123M for Phase 3 trial of ex-Astellas drug in thyroid eye disease

Investors are pumping $123 million into a tiny Michigan biotech that is resurrecting an Astellas cancer drug for an eye disease that has attracted lots of VC and pharma attention in recent years. Sling Therapeutics ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at endpoints.news →

More in Health & Medicine

Tanzania: Pemba Residents Encouraged to Donate Blood

[Daily News] Pemba -- A SAFE blood donation campaign has been rolled out across Pemba's four districts as health officials seek to increase supplies for hospitals facing high demand for transfusions.

  • Pemba residents encouraged to donate blood for high demand in local hospitals.
  • Safe blood donation campaign launched in four districts of Pemba, Tanzania.
  • Eligible donors can donate every three months (men) or twice a year (women).

More from Wednesday 16 September →